LLY logo

Eli Lilly And Company (LLY) CAPEX

Annual CAPEX

$7.39 B
+$4.41 B+147.62%

31 December 2023

LLY CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$4.17 B
+$2.77 B+197.32%

30 September 2024

LLY Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$8.31 B
+$169.60 M+2.08%

30 September 2024

LLY TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LLY CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+147.6%+4.2%+30.2%
3 y3 years+264.3%+815.5%+261.4%
5 y5 years+144.9%+1122.8%+403.3%

LLY CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+273.6%at high+815.5%at high+319.9%
5 y5 yearsat high+446.1%at high+1437.3%at high+578.6%
alltimeall timeat high+1918.0%at high>+9999.0%at high+4996.6%

Eli Lilly And Company CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$4.17 B(+197.3%)
$8.31 B(+2.1%)
June 2024
-
$1.40 B(+29.6%)
$8.14 B(+7.5%)
Mar 2024
-
$1.08 B(-34.4%)
$7.57 B(+2.4%)
Dec 2023
$7.39 B(+147.6%)
$1.65 B(-58.7%)
$7.39 B(+15.9%)
Sept 2023
-
$4.00 B(+378.4%)
$6.38 B(+110.5%)
June 2023
-
$836.30 M(-7.4%)
$3.03 B(+0.8%)
Mar 2023
-
$903.50 M(+41.5%)
$3.01 B(+0.8%)
Dec 2022
$2.99 B(+50.9%)
$638.60 M(-2.1%)
$2.99 B(+4.9%)
Sept 2022
-
$652.10 M(-19.9%)
$2.85 B(+7.4%)
June 2022
-
$813.60 M(-7.7%)
$2.65 B(+11.9%)
Mar 2022
-
$881.00 M(+76.4%)
$2.37 B(+19.7%)
Dec 2021
$1.98 B(-2.5%)
$499.40 M(+9.6%)
$1.98 B(-13.9%)
Sept 2021
-
$455.60 M(-14.2%)
$2.30 B(+1.8%)
June 2021
-
$531.30 M(+8.0%)
$2.26 B(+0.4%)
Mar 2021
-
$492.10 M(-40.0%)
$2.25 B(+10.9%)
Dec 2020
$2.03 B(+49.9%)
$819.50 M(+97.4%)
$2.03 B(+32.1%)
Sept 2020
-
$415.10 M(-20.7%)
$1.54 B(+5.1%)
June 2020
-
$523.20 M(+92.8%)
$1.46 B(+19.4%)
Mar 2020
-
$271.30 M(-16.9%)
$1.22 B(-9.6%)
Dec 2019
$1.35 B(-55.2%)
$326.50 M(-4.3%)
$1.35 B(-18.0%)
Sept 2019
-
$341.10 M(+19.6%)
$1.65 B(+2.6%)
June 2019
-
$285.30 M(-28.8%)
$1.61 B(-49.4%)
Mar 2019
-
$400.60 M(-35.8%)
$3.18 B(+5.4%)
Dec 2018
$3.02 B(+39.5%)
$623.70 M(+108.0%)
$3.02 B(+4.5%)
Sept 2018
-
$299.80 M(-83.9%)
$2.89 B(-4.9%)
June 2018
-
$1.86 B(+685.7%)
$3.04 B(+117.0%)
Mar 2018
-
$236.50 M(-52.1%)
$1.40 B(-35.3%)
Dec 2017
$2.16 B(+98.1%)
$493.50 M(+10.2%)
$2.16 B(+1.3%)
Sept 2017
-
$447.70 M(+102.0%)
$2.13 B(+11.5%)
June 2017
-
$221.60 M(-77.9%)
$1.91 B(-1.2%)
Mar 2017
-
$1.00 B(+115.3%)
$1.94 B(+77.5%)
Dec 2016
$1.09 B(-32.8%)
$464.80 M(+104.3%)
$1.09 B(-7.6%)
Sept 2016
-
$227.50 M(-7.3%)
$1.18 B(-7.5%)
June 2016
-
$245.40 M(+59.0%)
$1.28 B(-8.2%)
Mar 2016
-
$154.30 M(-72.2%)
$1.39 B(-14.4%)
Dec 2015
$1.63 B(+3.9%)
$554.20 M(+71.3%)
$1.63 B(-11.6%)
Sept 2015
-
$323.50 M(-10.1%)
$1.84 B(-1.0%)
June 2015
-
$359.90 M(-7.4%)
$1.86 B(+6.0%)
Mar 2015
-
$388.60 M(-49.3%)
$1.75 B(+11.9%)
Dec 2014
$1.57 B(+43.2%)
$767.10 M(+124.4%)
$1.57 B(+16.5%)
Sept 2014
-
$341.90 M(+34.1%)
$1.34 B(+7.0%)
June 2014
-
$254.90 M(+26.2%)
$1.26 B(+10.4%)
Mar 2014
-
$202.00 M(-62.9%)
$1.14 B(+4.0%)
Dec 2013
$1.09 B(+4.7%)
$545.20 M(+114.8%)
$1.09 B(+9.5%)
Sept 2013
-
$253.80 M(+86.1%)
$998.10 M(+3.9%)
June 2013
-
$136.40 M(-13.6%)
$960.40 M(-7.5%)
Mar 2013
-
$157.90 M(-64.9%)
$1.04 B(-0.6%)
Dec 2012
$1.04 B(-38.3%)
$450.00 M(+108.2%)
$1.04 B(+19.0%)
Sept 2012
-
$216.10 M(+1.1%)
$877.30 M(-13.1%)
June 2012
-
$213.80 M(+30.1%)
$1.01 B(-24.5%)
Mar 2012
-
$164.30 M(-42.0%)
$1.34 B(-21.0%)
Dec 2011
$1.69 B(+42.7%)
$283.10 M(-18.8%)
$1.69 B(+0.5%)
Sept 2011
-
$348.60 M(-35.7%)
$1.68 B(+10.9%)
June 2011
-
$542.20 M(+4.5%)
$1.52 B(-0.8%)
Mar 2011
-
$519.00 M(+89.2%)
$1.53 B(+29.0%)
Dec 2010
$1.19 B(+38.8%)
$274.30 M(+49.8%)
$1.19 B(-5.8%)
Sept 2010
-
$183.10 M(-67.0%)
$1.26 B(+0.7%)
June 2010
-
$554.20 M(+216.5%)
$1.25 B(+43.2%)
Mar 2010
-
$175.10 M(-49.5%)
$873.10 M(+2.1%)
Dec 2009
$855.00 M(-20.0%)
$346.80 M(+99.0%)
$855.00 M(+9.1%)
Sept 2009
-
$174.30 M(-1.5%)
$783.90 M(-5.6%)
June 2009
-
$176.90 M(+12.7%)
$830.50 M(-13.0%)
Mar 2009
-
$157.00 M(-43.1%)
$955.00 M(-10.7%)
Dec 2008
$1.07 B(-1.2%)
$275.70 M(+24.8%)
$1.07 B(-7.8%)
Sept 2008
-
$220.90 M(-26.7%)
$1.16 B(-0.8%)
June 2008
-
$301.40 M(+11.1%)
$1.17 B(+5.0%)
Mar 2008
-
$271.20 M(-26.0%)
$1.11 B(+2.9%)
Dec 2007
$1.08 B
$366.70 M(+59.4%)
$1.08 B(-3.8%)
Sept 2007
-
$230.10 M(-6.5%)
$1.13 B(-3.9%)
June 2007
-
$246.20 M(+2.8%)
$1.17 B(+1.3%)
DateAnnualQuarterlyTTM
Mar 2007
-
$239.40 M(-41.6%)
$1.16 B(+7.3%)
Dec 2006
$1.08 B(-17.0%)
$410.00 M(+48.7%)
$1.08 B(-0.9%)
Sept 2006
-
$275.70 M(+19.1%)
$1.09 B(+1.6%)
June 2006
-
$231.40 M(+44.0%)
$1.07 B(-12.0%)
Mar 2006
-
$160.70 M(-61.7%)
$1.22 B(-6.3%)
Dec 2005
$1.30 B(-31.6%)
$419.60 M(+62.3%)
$1.30 B(-3.7%)
Sept 2005
-
$258.60 M(-31.5%)
$1.35 B(-12.8%)
June 2005
-
$377.70 M(+55.9%)
$1.55 B(-7.8%)
Mar 2005
-
$242.20 M(-48.5%)
$1.68 B(-11.7%)
Dec 2004
$1.90 B(+11.2%)
$470.00 M(+3.0%)
$1.90 B(-9.0%)
Sept 2004
-
$456.40 M(-10.2%)
$2.09 B(+3.7%)
June 2004
-
$508.10 M(+9.6%)
$2.01 B(+6.4%)
Mar 2004
-
$463.60 M(-29.5%)
$1.89 B(+10.8%)
Dec 2003
$1.71 B(+50.9%)
$657.80 M(+72.0%)
$1.71 B(+18.5%)
Sept 2003
-
$382.40 M(-1.4%)
$1.44 B(+4.5%)
June 2003
-
$387.80 M(+39.2%)
$1.38 B(+13.2%)
Mar 2003
-
$278.60 M(-28.7%)
$1.22 B(+7.6%)
Dec 2002
$1.13 B(+27.9%)
$390.90 M(+22.1%)
$1.13 B(+7.4%)
Sept 2002
-
$320.20 M(+41.0%)
$1.05 B(+9.6%)
June 2002
-
$227.10 M(+17.9%)
$961.20 M(+4.2%)
Mar 2002
-
$192.70 M(-38.5%)
$922.70 M(+4.4%)
Dec 2001
$884.00 M(+30.4%)
$313.40 M(+37.5%)
$884.00 M(+8.4%)
Sept 2001
-
$228.00 M(+20.9%)
$815.50 M(+9.5%)
June 2001
-
$188.60 M(+22.5%)
$744.50 M(+3.1%)
Mar 2001
-
$154.00 M(-37.1%)
$721.90 M(+6.5%)
Dec 2000
$677.90 M(+28.3%)
$244.90 M(+56.0%)
$677.90 M(+5.7%)
Sept 2000
-
$157.00 M(-5.4%)
$641.10 M(+28.5%)
June 2000
-
$166.00 M(+50.9%)
$499.00 M(-9.9%)
Mar 2000
-
$110.00 M(-47.1%)
$553.60 M(+4.8%)
Dec 1999
$528.30 M(+25.8%)
$208.10 M(+1296.6%)
$528.30 M(+11.0%)
Sept 1999
-
$14.90 M(-93.2%)
$476.00 M(-7.1%)
June 1999
-
$220.60 M(+160.4%)
$512.40 M(+20.0%)
Mar 1999
-
$84.70 M(-45.6%)
$426.90 M(+1.7%)
Dec 1998
$419.90 M(+14.6%)
$155.80 M(+203.7%)
$419.90 M(+0.8%)
Sept 1998
-
$51.30 M(-62.0%)
$416.70 M(-6.0%)
June 1998
-
$135.10 M(+73.9%)
$443.10 M(+15.0%)
Mar 1998
-
$77.70 M(-49.1%)
$385.30 M(+5.2%)
Dec 1997
$366.30 M(-17.5%)
$152.60 M(+96.4%)
$366.30 M(+23.5%)
Sept 1997
-
$77.70 M(+0.5%)
$296.70 M(-14.5%)
June 1997
-
$77.30 M(+31.7%)
$347.10 M(-13.5%)
Mar 1997
-
$58.70 M(-29.3%)
$401.50 M(-9.6%)
Dec 1996
$443.90 M(-19.5%)
$83.00 M(-35.2%)
$443.90 M(-14.5%)
Sept 1996
-
$128.10 M(-2.7%)
$519.10 M(-3.6%)
June 1996
-
$131.70 M(+30.3%)
$538.40 M(-3.1%)
Mar 1996
-
$101.10 M(-36.1%)
$555.50 M(+0.8%)
Dec 1995
$551.30 M(-4.4%)
$158.20 M(+7.3%)
$551.30 M(-11.3%)
Sept 1995
-
$147.40 M(-0.9%)
$621.20 M(+8.8%)
June 1995
-
$148.80 M(+53.6%)
$571.10 M(+1.7%)
Mar 1995
-
$96.90 M(-57.5%)
$561.50 M(-2.6%)
Dec 1994
$576.50 M(-9.0%)
$228.10 M(+134.4%)
$576.50 M(+2.8%)
Sept 1994
-
$97.30 M(-30.1%)
$560.80 M(-6.6%)
June 1994
-
$139.20 M(+24.4%)
$600.60 M(-1.1%)
Mar 1994
-
$111.90 M(-47.3%)
$607.40 M(-4.1%)
Dec 1993
$633.50 M(-36.8%)
$212.40 M(+54.9%)
$633.50 M(-21.8%)
Sept 1993
-
$137.10 M(-6.1%)
$810.40 M(+2.0%)
June 1993
-
$146.00 M(+5.8%)
$794.20 M(-15.8%)
Mar 1993
-
$138.00 M(-64.6%)
$943.00 M(-5.9%)
Dec 1992
$1.00 B(-12.3%)
$389.30 M(+222.0%)
$1.00 B(+5.9%)
Sept 1992
-
$120.90 M(-59.0%)
$946.40 M(-14.8%)
June 1992
-
$294.80 M(+49.6%)
$1.11 B(+1.4%)
Mar 1992
-
$197.10 M(-40.9%)
$1.09 B(-4.2%)
Dec 1991
$1.14 B(+13.4%)
$333.60 M(+17.0%)
$1.14 B(-6.4%)
Sept 1991
-
$285.20 M(+2.2%)
$1.22 B(+4.7%)
June 1991
-
$279.00 M(+14.1%)
$1.16 B(+7.0%)
Mar 1991
-
$244.60 M(-40.5%)
$1.09 B(+8.1%)
Dec 1990
$1.01 B(+81.7%)
$411.30 M(+78.9%)
$1.01 B(+69.0%)
Sept 1990
-
$229.90 M(+13.2%)
$596.00 M(+62.8%)
June 1990
-
$203.10 M(+24.6%)
$366.10 M(+124.6%)
Mar 1990
-
$163.00 M
$163.00 M
Dec 1989
$554.50 M
-
-

FAQ

  • What is Eli Lilly and Company annual capital expenditures?
  • What is the all time high annual CAPEX for Eli Lilly and Company?
  • What is Eli Lilly and Company annual CAPEX year-on-year change?
  • What is Eli Lilly and Company quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly CAPEX year-on-year change?
  • What is Eli Lilly and Company TTM capital expenditures?
  • What is the all time high TTM CAPEX for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM CAPEX year-on-year change?

What is Eli Lilly and Company annual capital expenditures?

The current annual CAPEX of LLY is $7.39 B

What is the all time high annual CAPEX for Eli Lilly and Company?

Eli Lilly and Company all-time high annual capital expenditures is $7.39 B

What is Eli Lilly and Company annual CAPEX year-on-year change?

Over the past year, LLY annual capital expenditures has changed by +$4.41 B (+147.62%)

What is Eli Lilly and Company quarterly capital expenditures?

The current quarterly CAPEX of LLY is $4.17 B

What is the all time high quarterly CAPEX for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly capital expenditures is $4.17 B

What is Eli Lilly and Company quarterly CAPEX year-on-year change?

Over the past year, LLY quarterly capital expenditures has changed by +$169.60 M (+4.24%)

What is Eli Lilly and Company TTM capital expenditures?

The current TTM CAPEX of LLY is $8.31 B

What is the all time high TTM CAPEX for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM capital expenditures is $8.31 B

What is Eli Lilly and Company TTM CAPEX year-on-year change?

Over the past year, LLY TTM capital expenditures has changed by +$1.93 B (+30.22%)